The therapeutic effect of testosterone on lipid profile in patients with chronic kidney disease
Phase 3
- Conditions
- Chronic kidney disease.Chronic kidney disease (CKD)
- Registration Number
- IRCT20191009045044N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
GFR less than 45
BMI 25 to30
Male Gender
Testestrone lower than 3.5 ng/lit
Exclusion Criteria
Any pituitery diseas
Liver dysfunction
Heart failure
Any thyroid disease
Using any fat depressors
Prostate cancer
Breast cancer
BPH with obstruction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Cholestrol. Timepoint: First of study and 3 months later. Method of measurement: Lab test.;Serum Triglyceride. Timepoint: First of study and 3 months later. Method of measurement: Lab test.;LDL Cholestrol. Timepoint: First of study and 3 months later. Method of measurement: Lab test.;HDL Cholestrol. Timepoint: First of study and 3 months later. Method of measurement: Lab test.
- Secondary Outcome Measures
Name Time Method Serum Testestrone. Timepoint: At the beginning of the study and three months later. Method of measurement: Lab test.